Expression of CENPE and Its Prognostic Role in Non-small Cell Lung Cancer
Overview
Authors
Affiliations
Background: Non-small cell lung cancer (NSCLC) is one of the most important causes of death worldwide. Most patients are diagnosed in the advanced stage and have a poor prognosis. This study was to investigate the expression and significance of CENPE in NSCLC.
Method: Collecting information about CENPE in the Oncoming database, and perform a further analysis of the data in the current database to conduct a meta-analysis for its functional role in NSCLC. Patient life cycle analysis using Kaplan-Meier Plotter and GEPIA databases are used to perform patient survival analysis.
Result: A total of 12 studies involved the expression of CENPE in NSCLC cancer tissues and normal tissues, including 1195 samples. CENPE was highly expressed in NSCLC cell carcinoma compared with the control group (P < 0.05). Moreover, the expression of CENPE was correlated with the overall survival rate of CENPE. The overall survival rate of patients with high expression of CENPE was poor, and the prognosis of patients with low expression of CENPE was better (P<0.05).
Conclusion: We propose high expression of CENPE in NSLCL tissue is related to the prognosis of NSCLC, which may provide important basis for the development of tumor drugs.
Targeting Kinesins for Therapeutic Exploitation of Chromosomal Instability in Lung Cancer.
Zhang C, Wu B, Thu K Cancers (Basel). 2025; 17(4).
PMID: 40002279 PMC: 11853690. DOI: 10.3390/cancers17040685.
Sun F, Zhao T Cancer Biomark. 2024; 41(2):165-178.
PMID: 39331093 PMC: 11492023. DOI: 10.3233/CBM-240074.
Analyzing the expression and clinical significance of CENPE in gastric cancer.
Wang J, Li X, Qiang X, Yin X, Guo L BMC Med Genomics. 2024; 17(1):119.
PMID: 38702677 PMC: 11067209. DOI: 10.1186/s12920-024-01887-7.
Yang Y, Wei Y, She Z Front Mol Biosci. 2024; 11:1366113.
PMID: 38560520 PMC: 10978661. DOI: 10.3389/fmolb.2024.1366113.
Maximizing Anticancer Response with MPS1 and CENPE Inhibition Alongside Apoptosis Induction.
Pinto B, Silva J, Silva P, Barbosa D, Sarmento B, Tavares J Pharmaceutics. 2024; 16(1).
PMID: 38258067 PMC: 10818680. DOI: 10.3390/pharmaceutics16010056.